NUEVOS DERIVADOS DE BENC(E)INDENO, PROCEDIMIENTO DE PREPARARLOS, COMPOSICION FARMACEUTICA QUE LOS CONTIENE, PROCEDIMIENTO DE PREPARARLA Y UTILIZACION DE AQUELLOS

NUEVOS DERIVADOS DE BENC[E]INDENO, PROCEDIMIENTO DE PREPARARLOS, COMPOSICION FARMACEUTICA QUE LOS CONTIENE, PROCEDIMIENTO DE PREPARARLA Y UTILIZACION DE AQUELLOS. LOS DERIVADOS RESPONDEN A LA FORMULA GENERAL (I) EN LA CUAL A REPRESENTA UN GRUPO DE LA FORMULA ALK-NR1R2 O REPRESENTA PIRIMIDINO, 2,3-EP...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: GYERTYAN ISTVAN, BUDAI ZOLTAN, BLASKO GABOR, MEZEI TIBOR, SIMIG GYULA, REITER KLARA
Format: Patent
Sprache:spa
Schlagworte:
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:NUEVOS DERIVADOS DE BENC[E]INDENO, PROCEDIMIENTO DE PREPARARLOS, COMPOSICION FARMACEUTICA QUE LOS CONTIENE, PROCEDIMIENTO DE PREPARARLA Y UTILIZACION DE AQUELLOS. LOS DERIVADOS RESPONDEN A LA FORMULA GENERAL (I) EN LA CUAL A REPRESENTA UN GRUPO DE LA FORMULA ALK-NR1R2 O REPRESENTA PIRIMIDINO, 2,3-EPOXIPROPILO O UN GRUPO DE LA FORMULA -C(O)NHR3. SE PREPARAN HACIENDO REACCIONAR OTROS DERIVADOS DE BENC[E]INDENO Y, SI SE DESEA, CONVIRTIENDO UN COMPUESTO DE LA FORMULA (I) ASI OBTENIDO EN UNA SAL DE ADICION DE ACIDO O UN DERIVADO DE AMONIO CUATERNARIO FAMACEUTICAMENTE ACEPTABLES, O LIBERANDO UNA BASE LIBRE DE LA FORMULA (I) DE UNA SAL DE LA MISMA Y/O SEPARANDO LOS ESTEREOISOMEROS Y/O LOS ISOMEROS OPTIMAMENTE ACTIVOS. LA INVENCION ES APLICABLE A LA PREPARACION DE COMPOSICIONES QUE POSEEN, ENTRE OTROS, EFECTOS ANTICONVULSIVOS Y ANTIANGINALES Y QUE SE EMPLEAN EN EL TRATAMIENTO DE CIERTAS ENFERMEDADES. A subject-matter of the invention are benz[e]indene derivatives of the generel formula wherein A represents a group of the formula in which latter alk means a C2-7 alkylene group, optionally substituted by a hydroxy group and R1 and R2 stand independently for hydrogen or a C1-7 alkyl, C2-7 alkenyl, C2-7 alkynyl, C3-7 cycloalkyl, mono-(C1-7)alkylamino-(C1-7)alkyl or di-(C1-7)alkylamino-(C1-7)alkyl group or R1 and R2 together with the nitrogen atom to which they are attached form a 4 to 7 membered heterocyclic ring, optionally comprising an oxygen atom or a further nitrogen atom, which latter may be substituted by a phenyl, benzyl, pyridyl, pyrimidinyl or C1-3 alkyl group which latter ones, in turn, may be substituted by a hydroxy or methoxy group or a halogen atom or a halophenyl group or R1 and R2 together with the nitrogen atom to which they are attached form a phthalimido group or A means a pyrimidino group, a 2,3-(epoxy)-propyl group or a group of the formula in which latter R3 stands for a C1-7 alkyl, C2-7 alkenyl or C3-8 cycloalkyl group and R denotes hydrogen or a C1-7 alkyl group, and their stereoisomers and optically active isomers and mixtures thereof, as well as acid addition salts and quaternary ammonium derivatives of these compounds. Moreover there are provided for a process for preparing these compounds, medicaments containing them and the use of these compounds.